SynthesisFrontiers in medicine2021

The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis.

Xueyang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.